Summary Slide.png (124.92 kB)

Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations

media

posted on 2021-06-10, 15:59 authored by Adis Rapid Journals on behalf of:, Jerry Li, Dana Nickens, Keith Wilner, Weiwei Tan

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s40487-021-00156-2

Usage metrics

Read the peer-reviewed publication

Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations

Oncology and Therapy

Keywords

dacomitinib EGFR inhibitor overall survival pharmacokinetics progression-free survival proton pump inhibitors

Licence

CC BY-NC 4.0

Evaluation of the Effect of Proton Pump Inhibitors on the Efficacy of Dacomitinib and Gefitinib in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports